Your 2 Top Profit Opportunities in 2020
Stocks in the biotech sector have generally held up well during the market sell-off caused by the COVID-19 pandemic. Two of the leading biotechnology exchange-traded funds (ETFs), the iShares Nasdaq Biotechnology ETF and the SPDR S&P Biotech ETF, have quickly rebounded from their lows and continue to outperform the broader S&P 500.
Several companies in this sector have delivered consistent gains during this stock market downturn. Here are two biotech stocks that appear to be solid picks for the rest of the year and beyond.
Source Fool.com